Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Managing Hyperkalaemia: Getting Patients to Optimal RAASi Therapy
Author(s): James Burton, Clara Bonanad Lozano, Aaron Wong ,et al Start date: Jul 02, 2025
.img-row:after { content: ""; clear: both; display: table; } .img-column { float: left; width: 50%; padding: 5px; } @media screen and (max-width: 500px) { .img-column { width: 100%; } } Join James Burton (University of Leicester, Leicester, UK), Clara Bonanad (University Clinical Hospital of Valencia, Valencia, ES), Aaron Wong (Princess of Wales Hospital, Bridgend, Wales, UK)… View more

Cardiovascular Renal Metabolic

Heart Failure
Hyperkalaemia in the Cardiorenal Patient - Navigating Guidelines & Real-World Data
Author(s): Clara Bonanad Lozano , Anjay Rastogi Added: 1 year ago
Dr Anjay Rastogi (David Geffen School of Medicine UCLA, US) and Dr Clara Bonanad (University Clinical Hospital of Valencia, ES) discuss the evolving management strategies of hyperkalaemia in heart failure and chronic kidney disease, in this short video series. In this three part discussion they cover the most recent guidelines from ACC, ESC and KDIGO, real-world evidence from the recent ZORA… View more

Heart Failure

Prevention & Chronic Conditions
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care
Author(s): Javed Butler , Dinesh Khullar , John JV McMurray , et al Added: 2 months ago
In this expert-led webinar moderated by Dr Vijay Chopra, leading clinicians review current and emerging strategies in aldosterone modulation, hyperkalaemia management, and cardiorenal therapeutics.Dr Javed Butler opens with a practical overview of aldosterone’s central role in heart failure and CKD, emphasising the importance of achieving guideline-directed RAAS inhibitor and MRA dosing. He… View more

Heart Failure

Prevention & Chronic Conditions
Aldosterone and Potassium in Heart Failure
Author(s): Laibah Arshad Khan , Adeena Jamil , Stephen J Greene , et al Added: 1 year ago

Heart Failure

Prevention & Chronic Conditions
The Aldosterone Story: New Chapters
Author(s): Vijay Chopra Added: 6 months ago

Heart Failure
Emerging Strategies in Aldosterone Inhibition: A Special Focus
Author(s): Vijay Chopra Added: 8 months ago
Guest Editor Dr Vijay Chopra discusses the motivation behind the newly curated Special Focus on mineralocorticoid receptor antagonists.Dr Chopra explores why this topic is more relevant than ever, particularly as the field moves beyond traditional aldosterone antagonists toward novel agents like finerenone and aldosterone synthase inhibitors.From addressing hyperkalaemia fears to identifying gaps… View more

Heart Failure
Mineralocorticoid Receptor Antagonists in Heart Failure
Author(s): Rishi Sethi , Pravesh Vishwakarma , Akshyaya Pradhan Added: 1 year ago

Heart Failure

MI/ACS
Decoding the Future of HF — Key Takeaways from 2024
Author(s): Muthiah Vaduganathan , Orly Vardeny , Added: 1 year ago
Recorded at American Heart Association 2024 in Chicago, Dr Muthiah Vaduganathan (Brigham and Women’s Hospital and Harvard Medical School, Boston, US), Dr Orly Vardeny (University of Minnesota Medical School, Minneapolis, US) and Prof Pardeep Jhund (University of Glasgow, Glasgow, UK) explore cardiometabolic disease in heart failure with mid-range or preserved ejection fraction (HFmrEF and HFpEF)… View more

Heart Failure
Constructing Practical Pathways for RAASi Management: A Review of Emerging Data
Author(s): Anjay Rastogi , Shelley Zieroth Added: 1 year ago
In this peer-to-peer discussion, Dr Anjay Rastogi (David Geffen School of Medicine UCLA, US) and Dr Shelley Zieroth (University of Manitoba, CA) summarise and distil emerging real-world data on modern practices and approaches to treating hyperkalaemia during RAASi therapy in cardiorenal patients to optimise RAASI therapy.Download the Free Infographic View more

Heart Failure
ARNI for Optimising HFrEF Management
Author(s): Massimo Iacoviello , Filippo M Sarullo , Claudio Bilato , et al Added: 7 months ago

Heart Failure